CNBX Pharmaceuticals Inc. CNBX
0.00 USD 0.00 (+0.00%)
At closeNov 12, 2026, 4:00 PM EST
0.0001 Day range 0.0001
0.00005 52-week range 0.0007
- YTD
- -75.00%
- 1 year
- -66.67%
News
defenseworld.net CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX - Get Free Report) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totaling 100,000…
defenseworld.net Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Drops By 97.5% CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX - Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 31st, there was short interest…
benzinga.com 'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report https://abcnews.go.com/Politics/trump-sign-executive-order-reclassifying-marijuana-officials/story?id=128472615
benzinga.com Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 17, 2025 - benzinga.com Cannabis Stock Gainers And Losers From July 16, 2025
benzinga.com Cannabis Stock Movers For July 10, 2025 
benzinga.com Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 9, 2025 
benzinga.com Marijuana Stock Movers For July 7, 2025 
benzinga.com Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 4, 2025 - benzinga.com Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 3, 2025
benzinga.com Marijuana Stock Movers For July 2, 2025 - benzinga.com Marijuana Stock Movers For July 1, 2025
- benzinga.com Cannabis Stock Movers For June 30, 2025
- benzinga.com Cannabis Stock Gainers And Losers From June 25, 2025
- benzinga.com Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 24, 2025
- benzinga.com Cannabis Stock Movers For June 18, 2025
- benzinga.com Cannabis Stock Gainers And Losers From June 13, 2025
- benzinga.com Marijuana Stock Movers For June 12, 2025
- benzinga.com 'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report https://www.marijuanamoment.net/gop-led-congressional-panel-demands-investigation-on-bidens-marijuana-rescheduling-process-citing-deviations-and-mental-health-hazards/
benzinga.com Marijuana Stock Movers For May 21, 2025 
benzinga.com Marijuana Stock Movers For May 15, 2025 
benzinga.com Marijuana Stock Movers For May 14, 2025 - benzinga.com Marijuana Stock Movers For May 12, 2025
- benzinga.com Marijuana Stock Movers For May 8, 2025
- benzinga.com Cannabis Stock Gainers And Losers From May 6, 2025
- benzinga.com Cannabis Stock Movers For April 24, 2025
benzinga.com Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 23, 2025 - benzinga.com Cannabis Stock Movers For April 22, 2025
- benzinga.com Cannabis Stock Gainers And Losers From April 10, 2025
- benzinga.com Marijuana Stock Movers For April 4, 2025
- benzinga.com Cannabis Stock Movers For March 31, 2025
- benzinga.com Marijuana Stock Movers For March 24, 2025
- benzinga.com Watching Cannabis Stocks; Marijuana Moment Reports 'Trump White House Invites Proposal On Federal Marijuana Legalization, Activist Says' https://www.marijuanamoment.net/trump-white-house-invites-proposal-on-federal-marijuana-legalization-activist-says/
- benzinga.com Cannabis Stock Gainers And Losers From August 5, 2024
- benzinga.com Marijuana Stock Movers For August 2, 2024
benzinga.com Cannabis Stock Gainers And Losers From August 16, 2023 GAINERS: Red White & Bloom Brands (OTC: RWBYF) shares closed up 300.00% at $0.04- benzinga.com Marijuana Stock Movers For August 2, 2023
prnewswire.com CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021 TEL AVIV, Israel and BETHESDA, Md., Oct. 19, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…
benzinga.com Cannabics Pharmaceuticals Announces Two New Provisional Patents: Compositions and Methods For Treating Cancer Cannabics Pharmaceuticals Inc. (OTC:CNBX), a global leader in the development of cancer-related cannabinoid-based medicine, announced on Monday that it has filed two new provisional patent…
prnewswire.com Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer TEL AVIV, Israel and BETHESDA, Md., Oct. 18, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…
prnewswire.com Cannabics Announces New Corporate Logo, New Website and New Company Presentation TEL AVIV, Israel and BETHESDA, Md., Sept. 30, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine and a…
prnewswire.com Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participate at the ICDP Summit in Boston TEL AVIV, Israel and BETHESDA, Md., Sept. 22, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…
prnewswire.com Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseases TEL AVIV, Israel and BETHESDA, Maryland, Sept. 21, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…
prnewswire.com Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine TEL AVIV, Israel and BETHESDA, Md., Sept. 13, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine and a…
prnewswire.com World-Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of Advisors TEL AVIV, Israel and BETHESDA, Maryland, Aug. 4, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…
prnewswire.com Cannabics Pharmaceuticals Appoints a Second Independent Board Member TEL AVIV, Israel and BETHESDA, Maryland, July 20, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…
prnewswire.com Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member TEL AVIV, Israel and BETHESDA, Md., July 7, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…
prnewswire.com Cannabics Pharmaceuticals' Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice TEL AVIV, Israel and BETHESDA, Md., June 28, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…
prnewswire.com Cannabics Pharmaceuticals to launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases TEL AVIV, Israel and BETHESDA, Maryland, June 17, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…
prnewswire.com Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program TEL AVIV, Israel and BETHESDA, Md., June 3, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine,…